Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other Non Operating Income (2016 - 2017)

Syndax Pharmaceuticals (SNDX) has disclosed Other Non Operating Income for 3 consecutive years, with -$76000.0 as the latest value for Q4 2017.

  • For Q4 2017, Other Non Operating Income fell 231.03% year-over-year to -$76000.0; the TTM value through Dec 2017 reached -$269000.0, down 756.1%, while the annual FY2025 figure was -$1.3 million, 419.43% down from the prior year.
  • Other Non Operating Income hit -$76000.0 in Q4 2017 for Syndax Pharmaceuticals, down from -$53000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $58000.0 in Q4 2016 and bottomed at -$87000.0 in Q2 2017.
  • Average Other Non Operating Income over 3 years is -$24090.9, with a median of -$18000.0 recorded in 2016.
  • Year-over-year, Other Non Operating Income surged 480.0% in 2016 and then plummeted 5400.0% in 2017.
  • Syndax Pharmaceuticals' Other Non Operating Income stood at $10000.0 in 2015, then soared by 480.0% to $58000.0 in 2016, then crashed by 231.03% to -$76000.0 in 2017.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$76000.0, -$53000.0, and -$87000.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.